Treatment (Number) | Treatment (Number) | 28 day mortality | p value |
---|---|---|---|
Sulbactam monotherapy (30) | Cefoperazone/Sulbactam (30) | 40% (12/30) | |
Sulbactam based combination therapy (45) | Cefoperazone/Sulbactam+ Imipenem/cilastatin (25) | 16% (4/25) | 0.048* |
Cefoperazone/Sulbactam+ Biapenem or Meropenem (10) | 33.3% (3/10) | 0.432 | |
Cefoperazone/Sulbactam+ Other antibiotic(10) | 33.3% (3/10) | 0.432 |